Patents by Inventor James R. Komorowski

James R. Komorowski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SLEEP-IMPROVING COMPOSITIONS AND METHODS OF USE
    Publication number: 20240382442
    Abstract: Disclosed herein are compositions comprising two or more sleep-inducing agonists and/or a sleep-inducing antagonist. The compositions are for promoting healthy sleep quality and treating, ameliorating, preventing, or reducing one or more symptoms associated with menopause. Also described herein are methods utilizing the aforementioned compositions.
    Type: Application
    Filed: May 15, 2024
    Publication date: November 21, 2024
    Inventors: James R. Komorowski, Devon Bernsley
  • GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING
    Publication number: 20240366525
    Abstract: Disclosed herein are compositions comprising a GLP-1R agonist composition, a DPP-4 inhibitor composition, or a combination of both. The description contained herein describes methods for inducing weight loss and/or boosting satiety in a subject. The compositions described herein may be formulated for oral administration, and in some embodiments, may further comprise enteric or pH-responsive coatings.
    Type: Application
    Filed: May 1, 2024
    Publication date: November 7, 2024
    Inventors: James R. Komorowski, Devon Bernsley, Sophia Ramirez
  • MAGNESIUM PICOLINATE COMPOSITIONS AND METHODS OF USE
    Publication number: 20240342147
    Abstract: The present application relates to magnesium picolinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable magnesium to mammals and treating or preventing symptoms of magnesium deficiency.
    Type: Application
    Filed: May 9, 2024
    Publication date: October 17, 2024
    Inventors: Deanna J. Nelson, James R. Komorowski
  • MAGNESIUM BIOTINATE COMPOSITIONS AND METHODS OF USE
    Publication number: 20240299364
    Abstract: The present application relates to magnesium biotinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable biotin to mammals and treating or preventing symptoms of biotin deficiency.
    Type: Application
    Filed: February 14, 2024
    Publication date: September 12, 2024
    Inventors: Deanna J. Nelson, James R. Komorowski
  • BETA-ADRENERGIC AGONIST AND MUSCARINIC ANTAGONIST COMPOSITIONS AND METHODS OF USING
    Publication number: 20240285666
    Abstract: Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.
    Type: Application
    Filed: April 30, 2024
    Publication date: August 29, 2024
    Inventors: James R. Komorowski, Sarah Sylla, Devon Bernsley
  • Curcumin compositions and methods of use as an NK3 antagonist
    Patent number: 12070482
    Abstract: Disclosed herein are compositions for treating, ameliorating, preventing, or reducing the symptoms associated with menopause and/or hot flashes. The compositions disclosed herein comprise a curcumin composition, a green tea extract composition, and a phycocyanin composition that act as neurokinin 3 receptor antagonists. Also described herein are methods utilizing the aforementioned compositions.
    Type: Grant
    Filed: September 1, 2023
    Date of Patent: August 27, 2024
    Assignee: Bonafide Health, LLC
    Inventors: James R. Komorowski, Sarah Sylla
  • Beta-adrenergic agonist and muscarinic antagonist compositions and methods of using
    Patent number: 12048712
    Abstract: Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.
    Type: Grant
    Filed: October 18, 2023
    Date of Patent: July 30, 2024
    Assignee: Bonafide Health, LLC
    Inventors: James R. Komorowski, Sarah Sylla, Devon Bernsley
  • Magnesium picolinate compositions and methods of use
    Patent number: 12016849
    Abstract: The present application relates to magnesium picolinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable magnesium to mammals and treating or preventing symptoms of magnesium deficiency.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: June 25, 2024
    Assignee: Bonafide Health, LLC
    Inventors: Deanna J. Nelson, James R. Komorowski
  • CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS
    Publication number: 20240148748
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Application
    Filed: November 16, 2023
    Publication date: May 9, 2024
    Inventor: James R. Komorowski
  • BETA-ADRENERGIC AGONIST AND MUSCARINIC ANTAGONIST COMPOSITIONS AND METHODS OF USING
    Publication number: 20240122958
    Abstract: Disclosed herein are compositions for supporting bladder health and/or treating, ameliorating, preventing, or reducing overactive bladder or the symptoms associated therewith. The compositions disclosed herein comprise a beta-adrenergic receptor agonist and at least one muscarinic receptor antagonist. Also described herein are methods utilizing the aforementioned compositions.
    Type: Application
    Filed: October 18, 2023
    Publication date: April 18, 2024
    Inventors: James R. Komorowski, Sarah Sylla, Devon Bernsley
  • PROBIOTIC AND FOLIC ACID COMPOSITIONS AND METHODS OF USING
    Publication number: 20240108048
    Abstract: Disclosed herein are oral formulations for treating, preventing, or ameliorating symptoms associated with bacterial vaginosis or yeast infections. The oral formulations disclosed herein comprise a probiotic composition and a supplement composition formulated as a single, multi-component formulation. Also described herein are methods utilizing the aforementioned oral formulations.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 4, 2024
    Inventors: James R. Komorowski, Sarah Sylla, Devon Bernsley
  • Magnesium biotinate compositions and methods of use
    Patent number: 11938117
    Abstract: The present application relates to magnesium biotinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable biotin to mammals and treating or preventing symptoms of biotin deficiency.
    Type: Grant
    Filed: August 31, 2017
    Date of Patent: March 26, 2024
    Assignee: Nutrition21, LLC
    Inventors: Deanna J. Nelson, James R. Komorowski
  • Magnesium biotinate compositions and methods of use
    Patent number: 11931342
    Abstract: The present application relates to magnesium biotinate compositions and methods of use. The methods and compositions disclosed herein are particularly useful for providing bioavailable biotin to mammals and treating or preventing symptoms of biotin deficiency.
    Type: Grant
    Filed: April 22, 2020
    Date of Patent: March 19, 2024
    Assignee: Nutrition21, LLC
    Inventors: Deanna J. Nelson, James R. Komorowski
  • POLYGLUTAMIC ACID COMPOSITIONS AND METHODS OF USING
    Publication number: 20240050354
    Abstract: Disclosed herein are compositions comprising one or more polyglutamic acid compounds. The compositions are for treating, ameliorating, preventing, or reducing the symptoms of vaginal dryness and the symptoms associated with menopause. Also described herein are compositions for treating, ameliorating, preventing, or reducing other symptoms of skin dryness of a subject's body, limbs, hands, feet, neck, or face, in people of all ages and genders. Also described herein are topical and suppository formulations of the compositions.
    Type: Application
    Filed: October 17, 2023
    Publication date: February 15, 2024
    Inventor: James R. Komorowski
  • Multiple Unit Dosage Form Having A Therapeutic Agent In Combination With A Nutritional Supplement
    Publication number: 20240016746
    Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.
    Type: Application
    Filed: September 25, 2023
    Publication date: January 18, 2024
    Inventor: James R. Komorowski
  • Chromium containing compositions for improving health and fitness
    Patent number: 11865121
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: January 9, 2024
    Assignee: Nutrition21, LLC
    Inventor: James R. Komorowski
  • Chromium containing compositions for improving health and fitness
    Patent number: 11857553
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: January 2, 2024
    Assignee: Nutrition21, LLC
    Inventor: James R. Komorowski
  • Curcumin compositions and methods of use as an NK3 antagonist
    Patent number: 11857594
    Abstract: Disclosed herein are compositions for treating, ameliorating, preventing, or reducing the symptoms associated with menopause and/or hot flashes. The compositions disclosed herein comprise a curcumin composition, a green tea extract composition, and a phycocyanin composition that act as neurokinin 3 receptor antagonists. Also described herein are methods utilizing the aforementioned compositions.
    Type: Grant
    Filed: October 18, 2022
    Date of Patent: January 2, 2024
    Assignee: JDS Therapeutics, LLC
    Inventors: James R. Komorowski, Sarah Sylla
  • CURCUMIN COMPOSITIONS AND METHODS OF USE AS AN NK3 ANTAGONIST
    Publication number: 20230414696
    Abstract: Disclosed herein are compositions for treating, ameliorating, preventing, or reducing the symptoms associated with menopause and/or hot flashes. The compositions disclosed herein comprise a curcumin composition, a green tea extract composition, and a phycocyanin composition that act as neurokinin 3 receptor antagonists. Also described herein are methods utilizing the aforementioned compositions.
    Type: Application
    Filed: September 1, 2023
    Publication date: December 28, 2023
    Inventors: James R. Komorowski, Sarah Sylla
  • Multiple unit dosage form having a therapeutic agent in combination with a nutritional supplement
    Patent number: 11850308
    Abstract: Compositions and methods for combination therapy are provided. The compositions comprise a multiple unit dosage form having both a therapeutic agent and a nutritional supplement. The combination therapy is useful for restoring a nutrient depletion associated with a particular disease state. Additionally, the combination therapy can prevent or attenuate the depletion of a nutrient caused, in whole or in part, by the co-administrated therapeutic drug. Methods of manufacturing the formulations are likewise described.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: December 26, 2023
    Assignee: Bonafide Health, LLC
    Inventor: James R. Komorowski